CareDx Inc. (CDNA)
NASDAQ
Real-time Data
01:30 PM
Day's Range
47.3252 wk Range
12.37Overview - CDNA - CareDx Inc.
Key Statistics
Valuation
Enterprise Value
2.07B
P/E (Trailing)
‪22.92‬
P/E (Forward)
‪35.18‬
PEG Ratio
‪-0.01‬
Price / Sales (TTM)
‪5.38‬
Price / Book
‪5.76‬
EV / EBITDA
‪167.02‬
Profitability
Gross Margin
‪73.50%‬
Profit Margin
‪24.23%‬
Operating Margin
‪0.19%‬
Return on Assets
‪-0.25%‬
Return on Equity
‪29.48%‬
Ownership
Shares Outstanding
51.48M
Float
49.46M
Short % of Shares Outstanding
‪12.07%‬
Held by Insiders
‪3.15%‬
Held by Institutions
‪103.41%‬
Price stats
Beta
‪2.41‬
50-Day Avg
‪35.17‬
200-Day Avg
‪23.18‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
7 analysts
Average price target
‪$ 52.33‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CDNA - CareDx Inc.
Peers - CDNA - CareDx Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- CDCDNANASDAQCareDx Inc.2.43BMarket Cap+73.11%52-week change22.92P/E (Trailing)‪24.23%‬Profit Margin
- NTRANASDAQNATERA INC (Common Stock) – ticker 45E47.23BMarket Cap+50.52%52-week change-220.14P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.43.33BMarket Cap-16.52%52-week change38.86P/E (Trailing)‪25.03%‬Profit Margin
- ILMNNASDAQIllumina, Inc.33.70BMarket Cap+55.77%52-week change41.01P/E (Trailing)‪18.33%‬Profit Margin
- GHNASDAQGuardant Health Inc.22.13BMarket Cap+61.54%52-week change-49.67P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings Inc.17.13BMarket Cap+23.58%52-week change36.41P/E (Trailing)‪17.66%‬Profit Margin
- ICICLRNASDAQICON plc13.38BMarket Cap-0.84%52-week change264.97P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - CDNA - CareDx Inc.
About
CareDx Inc. is a leading precision medicine company that discovers, develops, and commercializes clinically differentiated diagnostic solutions for transplant patients and caregivers. It specializes in genomics-based testing services, including AlloSure Kidney and AlloSure Heart for donor-derived cell-free DNA…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
